Literature DB >> 11022969

Garlic elicits a nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats.

S Kim-Park1, D D Ku.   

Abstract

1. The aims of the present study were to determine the characteristics of garlic extract-induced relaxation in rat isolated pulmonary arteries, its susceptibility to changes in oxygen tension and its protective effect against hypoxic pulmonary vasoconstriction. 2. In normoxia, garlic extract (3-500 microg/mL) produced a dose- and nitric oxide (NO)-dependent relaxation. Following 60 min hypoxia, maximum garlic relaxation was reduced compared with control (mean (-SEM) -86 +/- 3 vs-69 +/- 2% of phenylephrine (PE) precontraction, respectively), but recovered after 60 min reoxygenation (-85 +/- 3% PE precontraction). 3. Acetylcholine (0.1 micromol/L)-induced NO-dependent relaxation was reduced from a control value of -76 +/- 1% to -46 +/- 4% during hypoxia and was further reduced to -35 +/- 2 % after reoxygenation. 4. In endothelium-intact arteries, hypoxic exposure resulted in a triphasic response: early transient contraction (+24 +/- 4%), followed by transient relaxation (-37 +/- 7%) and then sustained contraction (+62 +/- 5%). 5. Pretreatment with NG-nitro-L-arginine methyl ester abolished the early transient contraction, moderately attenuated the sustained contraction and had no effect on the transient relaxation. Mechanical endothelial disruption inhibited all hypoxia-induced vascular changes. 6. Garlic pretreatment had no effect on the early transient contraction (+25 +/- 4%), but inhibited the transient relaxation (-5 +/- 3%; P<0.05) and the sustained contraction (+26 +/- 5%; 7. Garlic also significantly inhibited endothelin-l-induced contractions in a dose-dependent manner. 8. These findings show that garlic extract modulates the production and function of both endothelium-derived relaxing and constricting factors and this may contribute to its protective effect against hypoxic pulmonary vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022969     DOI: 10.1046/j.1440-1681.2000.03333.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

1.  Improved microvascular reactivity after aged garlic extract intake is not mediated by hydrogen sulfide in older adults at risk for cardiovascular disease: a randomized clinical trial.

Authors:  Renata Leitão; Gustavo Vieira de Oliveira; Cristina Rezende; Mônica Volino-Souza; Jacilene Mesquita; Leandro Lara de Carvalho; Thiago Silveira Alvares
Journal:  Eur J Nutr       Date:  2022-05-04       Impact factor: 4.865

2.  Garlic intake is an independent predictor of endothelial function in patients with ischemic stroke.

Authors:  K-K Lau; Y-H Chan; Y-K Wong; K-C Teo; K-H Yiu; S Liu; L S-W Li; X-O Shu; S-L Ho; K H Chan; C-W Siu; H-F Tse
Journal:  J Nutr Health Aging       Date:  2013-07       Impact factor: 4.075

Review 3.  Chemical constituents and medicinal properties of Allium species.

Authors:  Salim M A Bastaki; Shreesh Ojha; Huba Kalasz; E Adeghate
Journal:  Mol Cell Biochem       Date:  2021-08-21       Impact factor: 3.396

4.  Short-term impact of aged garlic extract on endothelial function in diabetes: A randomized, double-blind, placebo-controlled trial.

Authors:  Sajad Hamal; Lavanya Cherukuri; Divya Birudaraju; Suguru Matsumoto; April Kinninger; Bhanu T Chaganti; Ferdinand Flores; Kashif Shaikh; Sion K Roy; Matthew J Budoff
Journal:  Exp Ther Med       Date:  2019-12-27       Impact factor: 2.447

Review 5.  Natural Products in Cardiovascular Diseases: The Potential of Plants from the Allioideae Subfamily (Ex-Alliaceae Family) and Their Sulphur-Containing Compounds.

Authors:  Jorge M Alves-Silva; Mónica Zuzarte; Henrique Girão; Lígia Salgueiro
Journal:  Plants (Basel)       Date:  2022-07-25

6.  Effect of garlic on cardiovascular disorders: a review.

Authors:  Sanjay K Banerjee; Subir K Maulik
Journal:  Nutr J       Date:  2002-11-19       Impact factor: 3.271

7.  Garlic powder intake and cardiovascular risk factors: a meta-analysis of randomized controlled clinical trials.

Authors:  Jin Sook Kwak; Ji Yeon Kim; Ju Eun Paek; You Jin Lee; Haeng-Ran Kim; Dong-Sik Park; Oran Kwon
Journal:  Nutr Res Pract       Date:  2014-11-28       Impact factor: 1.926

8.  Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis.

Authors:  Xiao-Bei Si; Xu-Min Zhang; Shuai Wang; Yu Lan; Shuo Zhang; Lin-Yu Huo
Journal:  World J Gastroenterol       Date:  2019-10-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.